Aerospace & Defense Stocks

Business

Nvidia's Earnings Loom: Does Timing Your Buy Before Feb. 25 Matter? Historical Data Suggests Patience

As Nvidia prepares to report its fiscal Q4 earnings on February 25th, investors are weighing whether to buy ahead of the event. While the AI chip leader's long-term story remains compelling, a look at its recent post-earnings stock performance reveals a pattern that favors a measured approach over trying to time the market.

Feb 2, 2026

The $50K Retirement Blueprint: How Much You Really Need to Save

Achieving a comfortable, $50,000-a-year retirement lifestyle is a common goal for many Americans. We break down the savings target, the critical role of Social Security, and the key factors that can make this financial milestone more attainable.

Feb 2, 2026

Business

Navigating Economic Uncertainty: Nine Practical Strategies to Fortify Your Savings in 2026

Amid persistent inflation and shifting trade policies, building a robust financial safety net is more crucial than ever. Experts outline actionable steps to grow your savings, from debt management to smart account allocation.

Feb 2, 2026

World

Syrian Government Troops Advance on Kurdish-Held Hasakah Under Fragile U.S.-Brokered Truce

A convoy of Syrian government forces was observed moving toward the strategic northeastern city of Hasakah on Monday, implementing a ceasefire agreement that aims to reintegrate Kurdish-administered territories with Damascus.

Feb 2, 2026

FDA Rejects Aquestive's Oral Anaphylaxis Treatment, Leaving Patients Awaiting Epinephrine Alternative

The U.S. Food and Drug Administration has issued a complete response letter for Aquestive Therapeutics' oral film drug designed to treat severe allergic reactions, the company announced Monday, delaying a potential new option for millions at risk.

Feb 2, 2026

Business

Markets Edge Lower Ahead of Key Labor Data, Earnings Deluge

U.S. stock futures pointed to a lower open Monday as investors braced for a flood of corporate earnings and crucial labor market reports that could sway Federal Reserve policy expectations.

Feb 2, 2026

Business

Visa and Mastercard Post Strong Quarterly Gains, Fueling Debate Over Long-Term Value

The payments giants Visa and Mastercard reported robust revenue and earnings growth for their latest quarters, though their premium valuations continue to spark investor debate on which offers the superior long-term opportunity.

Feb 2, 2026

Business

Visa Posts Strong Q1 2026 Results, Fueled by Robust Consumer Spending and Cross-Border Growth

The global payments giant reported a 15% surge in net revenue and processed a record 69.4 billion transactions in its fiscal first quarter, signaling resilient consumer confidence and a rebound from previous quarters.

Feb 2, 2026

Business

Tyson Foods Soars on Chicken Demand, Weathers Beef Market Turmoil

Tyson Foods Inc. surpassed quarterly profit expectations, driven by resilient consumer demand for chicken. This strength helped offset significant challenges in its beef division, where historic herd shortages and soaring costs have reshaped the meat industry's landscape.

Feb 2, 2026

Trump Nominates Former Fed Governor Kevin Warsh to Helm Central Bank Amid Probe into Current Chair Powell

Former President Donald Trump has announced Kevin Warsh, a former Federal Reserve governor and economic advisor, as his pick to lead the central bank. The nomination comes as incumbent Chair Jerome Powell faces a federal investigation related to his congressional testimony.

Feb 2, 2026

Business

London's Historic Ibex House to Become Art Deco Hotel After Planning Nod

A Dominus and Cheyne Capital partnership wins City of London approval to convert the Grade II-listed Ibex House into a 382-room hotel, slated for a late 2028 opening, complete with a hospitality academy and restored pub.

Feb 2, 2026

Business

Eli Lilly Bets Nearly $2 Billion on Repertoire Immune Medicines to Pioneer Next-Generation Autoimmune Therapies

Pharmaceutical giant Eli Lilly enters a strategic collaboration potentially worth up to $1.93 billion with biotech firm Repertoire Immune Medicines, aiming to develop precision treatments for autoimmune diseases that move beyond broad immunosuppression.

Feb 2, 2026

Business

Crystal International Bets Big on Automation with New China Logistics Hub

Hong Kong apparel giant Crystal International is investing in a high-tech logistics center in China, aiming to slash fabric transfer times by 75% and power operations with solar energy as part of its broader smart manufacturing push.

Feb 2, 2026

Business

Arctic Vision Bolsters Global Eye Care Ambitions with Strategic Acquisition of MDCO's Device Unit

Chinese biotech firm Arctic Vision moves to create an integrated ophthalmology powerhouse by acquiring MDCO Technology's device business, combining drug and device expertise to address unmet needs in eye care.

Feb 2, 2026

Business

Huntington Bancshares Gains Analyst Favor: Price Target Boosted Amid Strong Outlook

Truist Securities raises its price target on Huntington Bancshares (HBAN) following a robust Q4 performance, as the regional bank forecasts record interest income growth and benefits from improving industry tailwinds.

Feb 2, 2026

Business

Scotiabank Trims Comcast Price Target Amid Broadband Subscriber Losses, Intensifying Competition

Scotiabank has lowered its price target for Comcast (CMCSA), reflecting ongoing pressure in its core broadband business as the media giant reports higher-than-expected customer losses in Q4 and faces fierce competition from fiber and fixed-wireless rivals.

Feb 2, 2026

Business

Wells Fargo Trims UnitedHealth Target by $30, Citing Medicare Advantage Headwinds

Wells Fargo lowered its price target on UnitedHealth Group (UNH) following its Q4 report and a disappointing Medicare rate proposal from regulators, highlighting pressures on the healthcare giant's key growth engine.

Feb 2, 2026

Business

Precious Metals Rout Rattles Global Markets as Investors Seek Shelter

A sharp sell-off in gold and silver, alongside falling oil prices, has sparked volatility across global markets at the start of a week packed with major earnings and central bank decisions.

Feb 2, 2026

Business

Quantum Computing's AI Play: A Deep Dive into the High-Stakes Race Between IonQ and D-Wave

In the shadow of tech giants, two quantum computing specialists, IonQ and D-Wave Quantum, are vying for investor attention with distinct approaches to AI. While both remain speculative bets, a closer look at their technology, finances, and market position reveals one as a potentially less volatile choice for those venturing into this frontier.

Feb 2, 2026

Business

Zegna's Direct-to-Consumer Pivot Fuels Growth, Offsets Wholesale Retreat in 2025

The Ermenegildo Zegna Group reported a 1.1% organic revenue increase to €1.91 billion for 2025, powered by robust DTC performance. While annual sales dipped slightly on a reported basis, a strong fourth-quarter acceleration signals the payoff of its strategic channel shift.

Feb 2, 2026